BATON ROUGE, La., Aug. 18, 2017 -- Amedisys, Inc. (NASDAQ:AMED) today announced that its management will participate in the following healthcare conferences in September.
September 6, 2017 at 3:35 p.m. ET at the Wells Fargo Securities 2017 Healthcare Conference in Boston, Massachusetts.
September 7, 2017 at 9:40 a.m. ET at the Baird 2017 Global Healthcare Conference in New York, New York
To access a live webcast and copies of any related presentation materials, please log on through our website at http://investors.amedisys.com.
About Amedisys
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 16,000 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 340,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact: Amedisys, Inc. David Castille Managing Director, Finance 855.259.2046 [email protected]


Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 



